Gene · 3047
Papers4,047
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 4,047
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pharmacological Induction of Fetal Hemoglobin in β-Thalassemia and Sickle Cell Disease: An Updated Perspective. | Pharmaceuticals (Basel) | 2022 | 35745672 | PubTator, text mining | PubMed |
| DIA-Based Proteomic Analysis of Plasma Protein Profiles in Patients with Severe Acute Pancreatitis. | Molecules | 2022 | 35745003 | PubTator, text mining | PubMed |
| Generation of TRIM28 Knockout K562 Cells by CRISPR/Cas9 Genome Editing and Characterization of TRIM28-Regulated Gene Expression in Cell Proliferation and Hemoglobin Beta Subunits. | Int J Mol Sci | 2022 | 35743282 | PubTator, text mining | PubMed |
| Gene Editing-Based Technologies for Beta-hemoglobinopathies Treatment. | Biology (Basel) | 2022 | 35741383 | PubTator, text mining | PubMed |
| Single Nucleotide Polymorphisms in XMN1-HBG2, HBS1L-MYB, and BCL11A and Their Relation to High Fetal Hemoglobin Levels That Alleviate Anemia. | Diagnostics (Basel) | 2022 | 35741184 | PubTator, text mining | PubMed |
| Immunomodulatory Properties of Human Breast Milk: MicroRNA Contents and Potential Epigenetic Effects. | Biomedicines | 2022 | 35740242 | PubTator, text mining | PubMed |
| Metabolic sensor O-GlcNAcylation regulates erythroid differentiation and globin production via BCL11A. | Stem Cell Res Ther | 2022 | 35739577 | PubTator, text mining | PubMed |
| Metabolic reprogramming under hypoxic storage preserves faster oxygen unloading from stored red blood cells. | Blood Adv | 2022 | 35736672 | PubTator, text mining | PubMed |
Molecular Determination of Vascular Endothelial Growth Factor, miRNA-423 Gene Abnormalities by Utilizing ARMS-PCR and Their Association with Fetal Hemoglobin Expression in the Patients with Sickle Cell Disease. | Curr Issues Mol Biol | 2022 | 35735616 | PubTator, text mining | PubMed |
| [Hypoxia promotes erythroid differentiation of human K562 cells by upregulating endothelial PAS domain-containing protein 1 (EPAS1) expression]. | Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi | 2022 | 35732606 | PubTator, text mining | PubMed |
| miRNA-486-5p: signaling targets and role in non-malignant disease. | Cell Mol Life Sci | 2022 | 35731367 | PubTator, text mining | PubMed |
| Beneficial Effect of Edoxaban on Preventing Atrial Fibrillation and Coagulation by Reducing Inflammation via HBG1/HBD Biomarkers. | Front Pharmacol | 2022 | 35721103 | PubTator, text mining | PubMed |
| Effect of Chinese Herbal Medicine Therapy on Risks of Overall, Diabetes-Related, and Cardiovascular Diseases-Related Mortalities in Taiwanese Patients With Hereditary Hemolytic Anemias. | Front Pharmacol | 2022 | 35712707 | PubTator, text mining | PubMed |
| 6-Valent Virus-Like Particle-Based Vaccine Induced Potent and Sustained Immunity Against Noroviruses in Mice. | Front Immunol | 2022 | 35711416 | PubTator, text mining | PubMed |
| Lewis b antigen is a common ligand for genogroup I norovirus strains. | FEBS Open Bio | 2022 | 35711036 | PubTator, text mining | PubMed |
| Building regulatory landscapes reveals that an enhancer can recruit cohesin to create contact domains, engage CTCF sites and activate distant genes. | Nat Struct Mol Biol | 2022 | 35710842 | PubTator, text mining | PubMed |
| Analysis of rare thalassemia genetic variants based on third-generation sequencing. | Sci Rep | 2022 | 35701592 | PubTator, text mining | PubMed |
| Enhancer-gene specificity in development and disease. | Development | 2022 | 35686641 | PubTator, text mining | PubMed |
| CRISPR-Cas technology a new era in genomic engineering. | Biotechnol Rep (Amst) | 2022 | 35686011 | PubTator, text mining | PubMed |
| MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers. | Genes Dis | 2022 | 35685482 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3047/papers?page=33